Doctor Explains How To Fix Hashimoto’s Thyroiditis in 2026 (real results)

Summary

The video argues that people with Hashimoto’s may continue to experience fatigue, brain fog, weight gain, and other symptoms even when their TSH is considered normal. Dr. Jones says this can happen because TSH alone does not show the full picture of thyroid hormone activity, autoimmune activity, or other factors that affect how someone feels.

The video presents a functional-medicine approach alongside standard thyroid treatment. Its central metaphor is that levothyroxine replaces some of the “furniture” lost when the thyroid is damaged, but does not put out the “fire” of the autoimmune process. The presenter says levothyroxine is important and can be essential, while arguing that additional factors may also need attention.

Main ideas

• TSH is only one part of thyroid assessment. The presenter says a broader panel may include TSH, free T4, free T3, reverse T3, thyroid antibodies (TPO and thyroglobulin), and nutrients such as vitamin D, selenium, iron, and B12.
• Standard care is described as focusing mainly on hormone replacement. According to the video, treatment commonly centers on levothyroxine and TSH monitoring; mildly abnormal results may lead to monitoring rather than treatment. The presenter says conventional care does not have an FDA-approved medication specifically indicated to stop Hashimoto’s autoimmune attack.
• Symptoms and lab values may not always align. The video notes that some treated patients report ongoing symptoms despite a normal TSH and says antibodies can indicate autoimmune activity. It also emphasizes that feeling better and lowering antibody levels may be separate outcomes.
• The presenter’s functional-medicine framework has five areas to address:
  1. Gut health: The video discusses a possible link between gut-barrier problems and immune activity, while acknowledging this is an active area of research.
  2. Inflammation: It recommends an anti-inflammatory approach and mentions selenium, noting that its effects on TPO antibodies may vary.
  3. Nutritional deficiencies: It highlights vitamin D, selenium, iron, B12, and zinc as nutrients relevant to thyroid function.
  4. Dietary triggers: Gluten and the autoimmune protocol (AIP) diet are discussed. The presenter notes that evidence for non-celiac gluten sensitivity is less clear and that symptoms may improve without antibody levels changing.
  5. Stress and nervous-system regulation: Sleep, stress management, and nervous-system practices are presented as part of the overall approach.
• The video promotes additional therapies, with caveats about the evidence:
  • Low-dose naltrexone (LDN): Described as an off-label option being explored for immune modulation; the presenter says evidence is limited.
  • BPC-157 and KPV peptides: Presented as possible gut-related or anti-inflammatory supports. The video acknowledges that human clinical evidence is limited and describes these approaches as experimental.
  • GLP-1 medications: Discussed as tools for metabolic dysfunction and weight management that may reduce inflammation indirectly. The presenter says they do not specifically treat thyroid autoimmunity.
• The presenter describes a combined program that pairs functional-medicine care with advanced metabolic or peptide therapies. A case involving a patient named Maria is offered as an anecdote, not as clinical-trial evidence.

Proposed process described in the video

1. Assess thyroid and related factors. Begin with a broad lab evaluation rather than relying on TSH alone. The video also mentions stool testing and, in some cases, stress or urine testing.
2. Address foundational factors. Create an individualized plan focused on gut health, inflammation, nutrition, possible dietary triggers, and stress or nervous-system regulation.
3. Retest and adjust. Reassess at intervals and tailor the plan according to symptoms and lab results.
4. Consider additional therapies if needed. The presenter describes adding options such as LDN, peptides, or GLP-1 medications for selected patients, while acknowledging that some are off-label or experimental.
5. Plan for longer-term management. The video says the process may take up to 12 months, with foundational work first, possible advanced support later, and a final period devoted to maintenance and flare prevention.

The video stresses that this approach is not a quick fix and is intended to supplement—not replace—a person’s current doctor or prescribed medication. Its discussion of LDN, peptides, and other therapies reflects the presenter’s account; the video itself acknowledges that evidence for some of these approaches is limited. Treatment decisions should be discussed with a qualified clinician.

Speakers and sources featured

• Dr. Jones, DC: Main narrator and presenter.
• Dr. Allen: Identified by Dr. Jones as a functional-medicine specialist who works with him; not heard speaking in the subtitles.
• Maria: A patient mentioned in an anecdote; not heard speaking.
• Unspecified research and guidance: The presenter refers generally to studies, national testing guidelines, and research on thyroid testing, selenium, diet, LDN, peptides, and GLP-1 medications, but gives no specific citations in the subtitles.